Kam Shah has been involved in principal investing and investment banking since 2006. He currently serves on the boards of Advarra, Aspirion and StatLab. He previously served on the board of directors for HydraFacial and SeraCare Life Sciences. Prior to Linden, he was a Private Equity Associate at Sun Capital Partners, Inc. Mr. Shah began his career as an Investment Banking Analyst at Goldman, Sachs & Co. where he focused on M&A advisory, capital raising and leveraged buyout transactions.

Mr. Shah holds a Bachelor of Science in Finance with high honors from the University of Illinois at Urbana-Champaign and an MBA from the Stanford Graduate School of Business.